SRIF-14 (Human) [7466]



SRIF-14 (Human)


SMILES C[C@H](N)C(=O)NCC(=O)N[C@@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O
InChIKey VVEJUSYNERNRME-XGFVQVCISA-N
Sequence AGCKNFFWKTFTSC
HELM PEPTIDE1{A.G.[dC].[dK].N.[dF].F.[dW].K.[*C(=O)[C@@H]([C@@H](C)O)N* |$_R2;;;;;;;;_R1$|].S.C}$PEPTIDE1,PEPTIDE1,3:R3-12:R3$$$

Chemical Properties

Hydrogen bond acceptors 20
Hydrogen bond donors 19
Rotatable bonds 23
Log P -4.507
Molecular weight (Da) 1388.6
Stereochemistry info partial

Database connections

Model (AF2) SST3 SST4 SST5 SST1 SST2 SST3 SST5 SST2 SST2 SST3 SST4 SST1 SST5

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

SRIF-14 (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) SST3 SST4 SST5 SST1 SST2 SST3 SST5 SST2 SST2 SST3 SST4 SST1 SST5

Compound is not listed as a drug.